Outcomes of Radiotherapy in the First-Line Treatment of Recurrent/Metastatic Cervical Cancer: A Multicenter, Retrospective Study

被引：0
|
作者：
Peng, C. [1 ]
Li, X. [1 ]
Tang, W. [1 ]
Guo, Q. [1 ]
Wu, Q. [1 ]
Xie, P. [1 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1086
引用
收藏
页码：S189 / S189
页数：1
相关论文
共 50 条
  • [21] Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-Line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer
    Yoo, Changhoon
    Han, Boram
    Kim, Hyeong Su
    Kim, Kyu-pyo
    Kim, Deokhoon
    Jeong, Jae Ho
    Lee, Jae-Lyun
    Kim, Tae Won
    Kim, Jung Han
    Choi, Dae Ro
    Ha, Hong Il
    Seo, Jinwon
    Chang, Heung-Moon
    Ryoo, Baek-Yeol
    Zang, Dae Young
    CANCER RESEARCH AND TREATMENT, 2018, 50 (04): : 1324 - 1330
  • [22] KEYNOTE-826: A phase III randomized study of chemotherapy with or without pembrolizumab for first-line treatment of persistent, recurrent, or metastatic cervical cancer
    Fujiwara, K.
    Shapira-Frommer, R.
    Alexandre, J.
    Monk, B.
    Fehm, T.
    Colombo, N.
    Caceres, M. V.
    Hasegawa, K.
    Dubot, C.
    Li, J. J.
    Stein, K.
    Keefe, S. M.
    Tewari, K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [23] Cadonilimab Combined with Chemotherapy with or without Bevacizumab as First-Line Treatment in Recurrent or Metastatic Cervical Cancer (COMPASSION-13): A Phase 2 Study
    Lou, Hanmei
    Cai, Hongbing
    Huang, Xin
    Li, Guiling
    Wang, Li
    Liu, Fei
    Qin, Wenjing
    Liu, Ting
    Liu, Wei
    Wang, Zhongmin Maxwell
    Li, Baiyong
    Xia, Yu
    Wang, Jing
    CLINICAL CANCER RESEARCH, 2024, 30 (08) : 1501 - 1508
  • [24] A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer
    Vasile, E.
    Masi, G.
    Fornaro, L.
    Cupini, S.
    Loupakis, F.
    Bursi, S.
    Petrini, I.
    Di Donato, S.
    Brunetti, I. M.
    Ricci, S.
    Antonuzzo, A.
    Chiara, S.
    Amoroso, D.
    Andreuccetti, M.
    Falcone, A.
    BRITISH JOURNAL OF CANCER, 2009, 100 (11) : 1720 - 1724
  • [25] First-line treatment with irinotecan and raltitrexed in metastatic colorectal cancer -: Mature results of a multicenter phase II study
    Aparicio, J
    Vicent, JM
    Maestu, I
    Bosch, C
    Galán, A
    Busquier, I
    Llorca, C
    Garcerá, S
    Campos, JM
    López-Tendero, P
    Balcells, M
    ONCOLOGY, 2005, 68 (01) : 58 - 63
  • [26] A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer
    E Vasile
    G Masi
    L Fornaro
    S Cupini
    F Loupakis
    S Bursi
    I Petrini
    S Di Donato
    I M Brunetti
    S Ricci
    A Antonuzzo
    S Chiara
    D Amoroso
    M Andreuccetti
    A Falcone
    British Journal of Cancer, 2009, 100 : 1720 - 1724
  • [27] Weekly docetaxel and gemcitabine as first-line treatment for metastatic breast cancer:: Results of a multicenter phase II study
    Palmeri, S
    Vaglica, M
    Spada, S
    Filippelli, G
    Farris, A
    Palmeri, L
    Massidda, B
    Misino, A
    Ferraù, F
    Comella, G
    Leonardi, V
    Condemi, G
    Mangiameli, A
    De Cataldis, G
    Macaluso, MC
    Cajozzoo, M
    Iannitto, E
    Danova, M
    ONCOLOGY, 2005, 68 (4-6) : 438 - 445
  • [28] Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer
    Ilhan, Yusuf
    Tatli, Ali Murat
    Teker, Fatih
    Onder, Arif Hakan
    Kose, Fatih
    Geredeli, Caglayan
    Karaagac, Mustafa
    Kaplan, Muhammet Ali
    Inanc, Mevlude
    Aydin, Sabin Goktas
    Kargi, Aysegul
    Arak, Haci
    Ozturk, Banu
    Besen, Ali Ayberk
    Selvi, Oguzhan
    Korkmaz, Mustafa
    Oruc, Zeynep
    Bozkurt, Oktay
    Bilici, Ahmet
    Bayram, Selami
    Dae, Shute Ailia
    Ozdogan, Mustafa
    Coskun, Hasan Senol
    Goksu, Sema Sezgin
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (04) : 502 - 507
  • [29] CETUXIMAB FOR THE FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER
    Ubago, R.
    Castillo, M. A.
    Flores, S.
    Rodriguez, R.
    Beltran, C.
    VALUE IN HEALTH, 2011, 14 (07) : A433 - A434
  • [30] Cetuximab for the first-line treatment of metastatic colorectal cancer
    Meads, C.
    Round, J.
    Tubeuf, S.
    Moore, D.
    Pennant, M.
    Baylis, S.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 1 - 8
12345